Strategies for Effective Risk Management in Drug Safety

The landscape of drug safety is continuously evolving, and authorized under the US Food and Drug Administration (FDA) Amendments Act of 2007, the Risk Evaluation and Mitigation Strategy (REMS) Program plays a critical role in protecting patient safety by requiring targeted risk management measures for specific drugs and drug classes. These programs are implemented either during initial product approval or as post-marketing requirements when new safety concerns arise.

For sponsors, understanding and complying with REMS requirements is essential, both to meet necessary regulatory obligations and to streamline drug approval and maintain patient access to critical treatments. The FDA evaluates REMS on a case-by-case basis, considering multiple factors, including population size, disease severity, treatment duration, and potential adverse events. Noncompliance with REMS requirements can result in significant consequences, from regulatory warnings to product seizures and financial penalties.

This eBook provides a comprehensive guide to FDA REMS programs, covering key considerations, compliance requirements, and strategies for successful implementation. You will learn about:

• The six key factors the FDA considers when determining the need for a REMS program
• The five fundamental components of a REMS program, including Medication Guides, Elements to Assure Safe Use (ETASU), and implementation strategies
• Best practices for navigating REMS compliance, avoiding regulatory pitfalls, and preparing for FDA inspections
• The value of strategic partnerships in reducing the operational burden of REMS implementation

Download the eBook now to explore the essential components of REMS and how to ensure compliance while maintaining efficiency and patient safety.

Download Now

Complete the form to download the eBook.